Skip to main content

Table 5 Clinical and laboratory findings in incomplete KD in the 2000–2004 group and the 2010–2014 group (n = 228)

From: Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea

 

2000–2004 (n = 74)

2010–2014 (n = 154)

P

Age (month)

29.3 ± 24.8

26.9 ± 22.0

0.456

Sex (M/F)

44/30

98/56

0.562

Fever (day)

 Preadmission

5.5 ± 2.8

4.2 ± 1.5

< 0.001

 Total

7.9 ± 3.9

6.0 ± 1.6

< 0.001

Hospitalization (d)

8.6 ± 4.5

5.6 ± 1.7

< 0.001

Repeated IVIG, n (%)

6 (8.1)

7 (4.5)

0.358

CALs, n (%)

22 (29.7)

24 (15.6)

0.015

 Ectasia

19 (25.7)

23 (14.9)

0.067

 Aneurysm

3 (4.0)

1 (0.6)

0.102

WBC (/mm3)

15,500 ± 5000

14,800 ± 4900

0.291

 Neutrophil (%)

60.5 ± 17.1

61.6 ± 14.8

0.599

 Lymphocyte (%)

24.9 ± 13.7

27.7 ± 11.7

0.116

Hemoglobin (g/dL)

10.7 ± 0.8

11.4 ± 1.0

< 0.001

Platelet (/mm3)

324 ± 191

341 ± 108

0.010

Platelet, follow-up

550 ± 291

418 ± 146

< 0.001

CRP (mg/dL)

10.4 ± 6.8

8.0 ± 4.9

0.008

ESR (mm/h)

60 ± 23

70 ± 28

< 0.001

Total protein (g/dL)

6.4 ± 0.7

6.5 ± 0.6

0.703

Albumin (g/dL)

3.5 ± 0.4

3.9 ± 0.5

< 0.001

AST (IU/L)

43 ± 39

96 ± 297

0.030

ALT (IU/L)

65 ± 82

108 ± 174

0.021

ALT <40 IU, n (%)

42 (56.8)

81 (52.6)

0.888

ALT 40–100 IU, n (%)

18 (24.3)

32 (20.8)

0.616

ALT >100 IU, n (%)

14 (18.9)

41 (26.6)

0.241

  1. Values are mean ± SD or n (%). Abbreviations as in Table 1